Edelris
Edelris is a premier drug discovery CRO specializing in targeted protein degradation and induced-proximity therapeutics. Our Edelris Discovery Engine (EDEN™) platform seamlessly integrates a proprietary, 3D-rich, natural product-inspired Keymical Space™ with advanced Affinity Selection-Mass Spectrometry (AS-MS). This powerful synergy efficiently identifies high-quality hits for challenging targets, including novel E3 ligases and ternary complexes. By pairing innovative chemical matter with robust, label-free AS-MS screening, Edelris accelerates your proximity-based drug discovery programs into highly tractable lead candidates.
